PL2011796T3 - Induktor neurogenezy lub środek terapeutyczny do stosowania w neuropatii zawierający pochodną eteru alkilowego lub jej sól - Google Patents

Induktor neurogenezy lub środek terapeutyczny do stosowania w neuropatii zawierający pochodną eteru alkilowego lub jej sól

Info

Publication number
PL2011796T3
PL2011796T3 PL07742276T PL07742276T PL2011796T3 PL 2011796 T3 PL2011796 T3 PL 2011796T3 PL 07742276 T PL07742276 T PL 07742276T PL 07742276 T PL07742276 T PL 07742276T PL 2011796 T3 PL2011796 T3 PL 2011796T3
Authority
PL
Poland
Prior art keywords
salt
therapeutic agent
alkyl ether
ether derivative
neuropathy therapeutic
Prior art date
Application number
PL07742276T
Other languages
English (en)
Inventor
Noboru Iwakami
Shigeki Marubuchi
Tomohiro Okuda
Original Assignee
Toyama Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyama Chemical Co Ltd filed Critical Toyama Chemical Co Ltd
Publication of PL2011796T3 publication Critical patent/PL2011796T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/397—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having four-membered rings, e.g. azetidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL07742276T 2006-04-26 2007-04-24 Induktor neurogenezy lub środek terapeutyczny do stosowania w neuropatii zawierający pochodną eteru alkilowego lub jej sól PL2011796T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006122080 2006-04-26
PCT/JP2007/058841 WO2007125913A1 (ja) 2006-04-26 2007-04-24 アルキルエーテル誘導体またはその塩を含有する神経細胞新生誘導剤および精神障害治療剤
EP07742276.4A EP2011796B1 (en) 2006-04-26 2007-04-24 Neurogenesis inducer or neuropathy therapeutic agent comprising alkyl ether derivative or salt thereof

Publications (1)

Publication Number Publication Date
PL2011796T3 true PL2011796T3 (pl) 2015-03-31

Family

ID=38655439

Family Applications (1)

Application Number Title Priority Date Filing Date
PL07742276T PL2011796T3 (pl) 2006-04-26 2007-04-24 Induktor neurogenezy lub środek terapeutyczny do stosowania w neuropatii zawierający pochodną eteru alkilowego lub jej sól

Country Status (20)

Country Link
US (1) US20090093453A1 (pl)
EP (1) EP2011796B1 (pl)
JP (2) JP5695293B2 (pl)
KR (1) KR101374593B1 (pl)
CN (1) CN101432280B (pl)
AU (1) AU2007244409B2 (pl)
BR (1) BRPI0710239A2 (pl)
CA (1) CA2648898C (pl)
CY (1) CY1115643T1 (pl)
DK (1) DK2011796T3 (pl)
ES (1) ES2518371T3 (pl)
IL (1) IL194569A (pl)
MX (1) MX2008013728A (pl)
NO (1) NO342153B1 (pl)
NZ (1) NZ571975A (pl)
PL (1) PL2011796T3 (pl)
PT (1) PT2011796E (pl)
SI (1) SI2011796T1 (pl)
WO (1) WO2007125913A1 (pl)
ZA (1) ZA200808728B (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL215264B1 (pl) 2001-10-19 2013-11-29 Toyama Chemical Co Ltd Pochodne eteru alkilowego lub ich sole, sposób ich wytwarzania oraz kompozycja farmaceutyczna
SI2389937T1 (sl) 2002-06-14 2018-10-30 Toyama Chemical Co., Ltd, Farmacevtska sestava za izboljšanje možganske funkcije
SI2348022T1 (sl) * 2005-03-28 2013-05-31 Toyama Chemical Co., Ltd. Postopek proizvodnje 1-(3-(2-(1-benzotiofen-5-il)etoksi)propil)azetidin-3-ola ali soli le-tega
JP5255441B2 (ja) * 2006-08-04 2013-08-07 富山化学工業株式会社 アルキルエーテル誘導体またはその塩を含有するプロテインキナーゼｃ活性促進剤
PT2287160E (pt) * 2008-05-28 2014-06-24 Toyama Chemical Co Ltd Derivado de óxido de benzotiofeno e os seus sais
KR101716099B1 (ko) * 2013-09-12 2017-03-13 에프. 호프만-라 로슈 아게 인돌-카복스아마이드 유도체
SG10201907035TA (en) * 2014-01-31 2019-09-27 Fujifilm Toyama Chemical Co Ltd Post nerve injury rehabilitation effect-enhancing agent comprising alkyl ether derivative or salt thereof
US10238632B2 (en) 2015-06-11 2019-03-26 Fujifilm Toyama Chemical Co., Ltd. Sigma receptor-binding agent
US11304928B2 (en) 2015-12-25 2022-04-19 Fujifilm Toyama Chemical Co., Ltd. Tablet comprising 1-(3-(2-(1-benzothiophen-5-yl)ethoxy)propyl)azetidin-3-ol or salt thereof
US20190343796A1 (en) * 2016-12-28 2019-11-14 Fujifilm Toyama Chemical Co., Ltd. Composition for external use
EP3636262A4 (en) 2017-06-02 2020-06-10 FUJIFILM Toyama Chemical Co., Ltd. AGENT FOR PREVENTING OR TREATING ALZHEIMER-LIKE DEMENTIA
BR112019024851A2 (pt) 2017-06-02 2020-06-09 Fujifilm Toyama Chemical Co Ltd agente para evitar ou tratar atrofia cerebral
IL270910B2 (en) * 2017-06-02 2024-03-01 Fujifilm Toyama Chemical Co Ltd 1-(3-(2-(1-benzothiophene-5-yl)ethoxy)propyl)aztidine-3-ol or a salt thereof for use in suppressing cerebral atrophy
RU2019138538A (ru) 2017-06-02 2021-07-09 ФУДЖИФИЛМ Тояма Кемикал Ко., Лтд. СРЕДСТВО ДЛЯ УМЕНЬШЕНИЯ КОЛИЧЕСТВА АМИЛОИДНОГО β-БЕЛКА
EP3705121B1 (en) 2017-10-30 2023-08-30 FUJIFILM Toyama Chemical Co., Ltd. Emopamil binding protein binding agent and use thereof

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6294346B1 (en) 1991-07-08 2001-09-25 Neurospheres Holdings, Ltd. Use of multipotent neural stem cells and their progeny for the screening of drugs and other biological agents
JPH05284992A (ja) * 1992-04-14 1993-11-02 Sagami Chem Res Center 神経成長因子産生促進剤及びその製造法
GB9309749D0 (en) * 1993-05-12 1993-06-23 Boots Co Plc Therapeutic agents
JPH07285912A (ja) * 1994-04-19 1995-10-31 Asahi Chem Ind Co Ltd 新規化合物ａｍ５２２１
JP2733207B2 (ja) * 1995-05-18 1998-03-30 工業技術院長 繊維芽細胞成長因子キメラ蛋白質を含有する医薬組成物
AU1506499A (en) * 1997-12-12 1999-07-05 Toyama Chemical Co. Ltd. Alkyl ether derivatives or salts thereof and calcium antagonists containing the same
IL129178A0 (en) * 1999-03-25 2000-02-17 Yeda Res & Dev Induction of nerve generation
KR100641352B1 (ko) * 1999-06-11 2006-11-02 토야마 케미칼 컴퍼니 리미티드 Ｎ-알콕시알킬-ｎ,ｎ-디알킬아민 유도체 또는 그 염, 및이를 함유하는 신경퇴행성질환 치료제
GB2367554A (en) * 2000-10-04 2002-04-10 Lilly Co Eli Pharmacologically active amines
US20040030131A1 (en) * 2000-10-04 2004-02-12 Martine Keenan Pharmaceutical compounds
JP4303435B2 (ja) * 2001-02-26 2009-07-29 富山化学工業株式会社 ミトコンドリア機能賦活剤
JP4357802B2 (ja) * 2001-07-05 2009-11-04 武田薬品工業株式会社 ベンゼン環縮合５員複素環式化合物、その製造法および用途
WO2003004485A1 (en) * 2001-07-05 2003-01-16 Takeda Chemical Industries, Ltd. Benzo-fused 5-membered hetrocycle compounds, process for preparation of the same, and use thereof
JP4905752B2 (ja) * 2001-07-24 2012-03-28 エスティー・ラボ株式会社 揮発性有機塩素化合物センサ
PL215264B1 (pl) * 2001-10-19 2013-11-29 Toyama Chemical Co Ltd Pochodne eteru alkilowego lub ich sole, sposób ich wytwarzania oraz kompozycja farmaceutyczna
JP4537011B2 (ja) * 2002-03-01 2010-09-01 武田薬品工業株式会社 抗うつ剤
SI2389937T1 (sl) * 2002-06-14 2018-10-30 Toyama Chemical Co., Ltd, Farmacevtska sestava za izboljšanje možganske funkcije
JP2004256428A (ja) * 2003-02-25 2004-09-16 Science Univ Of Tokyo 神経栄養因子様プリン系化合物含有作用剤
KR101096528B1 (ko) * 2003-04-17 2011-12-20 토야마 케미칼 컴퍼니 리미티드 알킬에테르 유도체 또는 그 염을 함유하는 망막신경질환의예방·치료제
ATE504295T1 (de) * 2003-10-03 2011-04-15 Ono Pharmaceutical Co Nervenregenerationsförderer

Also Published As

Publication number Publication date
ES2518371T3 (es) 2014-11-05
US20090093453A1 (en) 2009-04-09
CN101432280B (zh) 2012-11-21
CN101432280A (zh) 2009-05-13
IL194569A (en) 2014-09-30
CA2648898C (en) 2015-01-20
BRPI0710239A2 (pt) 2011-08-09
EP2011796A1 (en) 2009-01-07
AU2007244409A1 (en) 2007-11-08
ZA200808728B (en) 2010-01-27
PT2011796E (pt) 2014-11-26
CA2648898A1 (en) 2007-11-08
JPWO2007125913A1 (ja) 2009-09-10
EP2011796A4 (en) 2010-07-07
NO342153B1 (no) 2018-04-03
JP5695293B2 (ja) 2015-04-01
KR20080111131A (ko) 2008-12-22
CY1115643T1 (el) 2017-01-04
EP2011796B1 (en) 2014-10-08
AU2007244409B2 (en) 2011-12-01
DK2011796T3 (da) 2014-10-27
JP2013177410A (ja) 2013-09-09
WO2007125913A1 (ja) 2007-11-08
IL194569A0 (en) 2009-08-03
MX2008013728A (es) 2009-01-07
KR101374593B1 (ko) 2014-03-17
SI2011796T1 (sl) 2015-02-27
NZ571975A (en) 2011-04-29
NO20084338L (no) 2008-11-19

Similar Documents

Publication Publication Date Title
ZA200808728B (en) Neurogenesis inducer or neuropathy Therapeutic agent comprising alkyl ether derivative or salt thereof
EP2051760A4 (en) ADMINISTRATION OF ANTI-THERAPY
EP2046430A4 (en) ADMINISTRATION OF ANTI-THERAPY
EP2101855A4 (en) ADMINISTRATION OF ANTI-THERAPY
EP2007435A4 (en) SYSTEM FOR TARGETED ADMINISTRATION OF THERAPEUTIC AGENTS
GB0609492D0 (en) Therapeutic agents
GB0608928D0 (en) Therapeutic agents
GB0601962D0 (en) Therapeutic agents
EP2093237A4 (en) ANTICANCER AGENT COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT
ITMI20060299A1 (it) Sistema per il trattamento di fumi
EG26729A (en) Method of support (consolidation) delivery of a worker to a well
ZA200806983B (en) Amide derivative or salt thereof
GB0616214D0 (en) Therapeutic Agents
IL196202A0 (en) Indazole derivatives for the treatment of hsp90-induced diseases
ITPN20060015U1 (it) "piedino di supporto per mobili"
PL2018164T3 (pl) Zastosowanie preparatów złożonych obejmujących środki przeciwgrzybicze
GB2432174B (en) Delivery system for downhole use
GB0611152D0 (en) Therapeutic agents
ZA200800698B (en) Pyrazole derivatives as therapeutic agents
EP2098228A4 (en) ANTI-INFLAMMATORY AGENT CONTAINING 2-AMINOPHENOL OR A DERIVATIVE THEREOF AS ACTIVE INGREDIENT
GB0620059D0 (en) Therapeutic agents
GB0609676D0 (en) Therapeutic agents
EP2140876A4 (en) THERAPEUTIC AGENT COMPRISING VASOHIBINE
GB0622195D0 (en) Therapeutic agents
EP1970075A4 (en) THERAPEUTIC AGENT FOR NEUROBLASTOM TARGETING ARID3b